Add to a list

Inactive Instrument

LOTUS PHARM Share Price OTC Bulletin Board

LTUS

US5457151042

Pharmaceuticals

OTC Markets Traded

End-of-day quote OTC Bulletin Board
- ^USD	-

31/07/23	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
26/11/21	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE

Lotus Pharmaceuticals Inc is a company mainly engaged in development, manufacture, and sales of pharmaceuticals. The Company produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. The Company's drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The Company operated in two business segment Wholesales segment and Retail segment. The Company's products include Maixin-valsartan capsules for the treatment of hypertension, Muxineye drops for the treatment of glaucoma and Yipubishan-octreotide Acetate Injection solution for the treatment of gastric ulcers. The Company mainly conducts its businesses in the domestic market and overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	9.74M 8.4M 7.89M 7.18M 13.5M 931M 13.69M 92.43M 36.22M 466M 36.55M 35.76M 1.55B	P/E 2009	3.88x	P/E 2010	4.84x
Enterprise Value	14.38M 12.42M 11.65M 10.61M 19.95M 1.38B 20.23M 137M 53.51M 689M 54M 52.83M 2.29B	EV / Sales 2009	1.02x	EV / Sales 2010	0.95x
Free-Float	99%	Yield 2009 *	-	Yield 2010	-

31/07/23	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
26/11/21	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE
28/09/21	Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund	RE
16/05/12	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS from LTUSE	CI
19/04/12	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS.E from LTUS	CI

12-30	Lotus Pharmaceutical Supports Street Medicine Program to Expand Access to Care for Those Most in Need	AQ
06/10/25	Lotus Enters License and Supply Agreement with Adalvo for Semaglutide injection	AQ
12/08/25	Lotus Pharmaceutical Achieves New First-Half Record in Revenue for 2025, While Q2 Impacted by FX and Timing of Lenalidomide Sales	AQ
21/02/25	Lotus announces FDA acceptance of Potential First-to-File ANDA Submission for Voclosporin soft gelatin capsules, a generic equivalent to Lupkynis	AQ
08/11/24	Lotus Achieves Second-Highest Quarterly Performance in Company History with 3Q24 Financial Results	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.37%	-3.44%	+14.85%	+65.22%	47.23B
OTSUKA HOLDINGS CO., LTD.	+0.21%	-1.71%	+51.94%	+122.92%	39.62B
CIPLA LIMITED	-0.03%	-2.18%	-8.57%	+15.75%	12.09B
ZYDUS LIFESCIENCES LIMITED	-1.41%	-6.33%	+13.09%	+72.20%	11.8B
KRKA, D. D.	+0.58%	0.00%	+30.65%	+148.80%	9.12B
GEDEON RICHTER	-0.62%	-0.84%	+22.33%	+40.09%	7.57B
ONO PHARMACEUTICAL CO., LTD.	+1.33%	+1.01%	+44.58%	-11.96%	7.1B
GLENMARK PHARMACEUTICALS LIMITED	-1.03%	+1.27%	+16.77%	+200.84%	6.87B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+0.63%	-2.55%	-30.10%	+23.92%	5.81B
Average	-0.07%	-0.62%	+17.28%	+75.31%	16.36B
Weighted average by Cap.	-0.13%	-2.14%	+23.88%	+82.11%

	2009	2010
Net sales	57.82M 49.92M 46.83M 42.66M 80.21M 5.53B 81.32M 549M 215M 2.77B 217M 212M 9.21B	72.7M 62.76M 58.88M 53.63M 101M 6.95B 102M 690M 270M 3.48B 273M 267M 11.58B
Net income	16.43M 14.19M 13.31M 12.12M 22.79M 1.57B 23.11M 156M 61.14M 787M 61.69M 60.36M 2.62B	14.42M 12.45M 11.68M 10.64M 20.01M 1.38B 20.29M 137M 53.67M 691M 54.16M 52.98M 2.3B
Net Debt	5.29 4.57 4.29 3.91 7.34 506.16 7.44 50.26 19.7 253.59 19.88 19.44 843.54	4.65 4.01 3.76 3.43 6.45 444.29 6.53 44.12 17.29 222.59 17.45 17.07 740.43

LOTUS PHARM Share Price OTC Bulletin Board

Stocks

LTUS

US5457151042

Pharmaceuticals

Valuation: LOTUS PHARM

Latest news : LOTUS PHARM

Press Releases: LOTUS PHARM

Managers and Directors: LOTUS PHARM

Generic Pharmaceuticals

Financials

Company Profile